Risk Assessment for Aflatoxin: I. Metabolism of Aflatoxin B1 by Different Species

Nancy J. Gorelick

Risk Analysis, 1990, vol. 10, issue 4, 539-559

Abstract: A comparison of the generation and detoxification of reactive aflatoxin B1 metabolites in different species may elucidate why animal species vary widely in sensitivity to aflatoxin B1 carcinogenicity, in addition to offering some perspective on how sensitive man may be to the carcinogenic effects of this mycotoxin. Scientific literature comparing the ability of cellular fractions from different species to metabolize aflatoxin B1 is reviewed. However, in vitro studies exclude components for multiple metabolic pathways, eliminating the possibility of competition between metabolic activation and detoxification. Quantification of metabolic activation by different species from these studies is therefore limited. The species‐specific carcinogenic potency of aflatoxin B1 may be reflected in levels of aflatoxin B1‐DNA adducts generated in vivo. The current paucity of quantitative information on human DNA adduct levels does not permit comparision between different species on this basis.

Date: 1990
References: View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://doi.org/10.1111/j.1539-6924.1990.tb00538.x

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:riskan:v:10:y:1990:i:4:p:539-559

Access Statistics for this article

More articles in Risk Analysis from John Wiley & Sons
Bibliographic data for series maintained by Wiley Content Delivery ().